Ribozyme and omics

Anti-cancer development based on RNA Platform technology Core competence to meet diverse unmet medical needs

Core Technology

RNA Replacement Enzyme

Tetrahymena Group Ⅰ Trans-splicing Ribozyme (World Leading Group)


  • Specificity by specific RNA-sensing riboswitch
  • Efficacy by dual function of RNA-cleavage & transgene induction




Features of Our Platform Technology

Retaining advantages / Overcoming disadvantages
of existing DNA/RNA technologies